Cargando…

A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs

BACKGROUND: Ciclosporin is approved for the treatment of atopic dermatitis (AD) in dogs and has been shown to be safe and effective. Placebo-controlled studies suggest that oclacitinib is a safe and effective alternative therapy. HYPOTHESIS/OBJECTIVES: To evaluate the efficacy and safety of oclaciti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Little, Peter R, King, Vickie L, Davis, Kylie R, Cosgrove, Sallie B, Stegemann, Michael R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Scientific Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365754/ https://www.ncbi.nlm.nih.gov/pubmed/25496303 http://dx.doi.org/10.1111/vde.12186

Ejemplares similares

A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel(®)) in client‐owned dogs with atopic dermatitis
por: Cosgrove, Sallie B., et al.
Publicado: (2013)

Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia
por: Gadeyne, Caroline, et al.
Publicado: (2014)

Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis
por: Visser, Marike, et al.
Publicado: (2022)

Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis
por: Cosgrove, Sallie B, et al.
Publicado: (2013)

Repeated oral dose tolerance in dogs treated concomitantly with ciclosporin and oclacitinib for three weeks
por: Panteri, Alessandro, et al.
Publicado: (2015)

Diminished antimicrobial drug use in dogs with allergic dermatitis treated with oclacitinib
por: Mwacalimba, Kennedy, et al.
Publicado: (2023)

The effect of a mixed cannabidiol and cannabidiolic acid based oil on client‐owned dogs with atopic dermatitis
por: Loewinger, Melissa, et al.
Publicado: (2022)

A masked, randomised clinical trial evaluating the efficacy and safety of lokivetmab compared to saline control in client‐owned dogs with allergic dermatitis
por: Van Brussel, Leen, et al.
Publicado: (2021)

An open, self-controlled study on the efficacy of topical indoxacarb for eliminating fleas and clinical signs of flea-allergy dermatitis in client-owned dogs in Queensland, Australia
por: Fisara, Petr, et al.
Publicado: (2014)

The Association Between the Use of Oclacitinib and Antibacterial Therapy in Dogs With Allergic Dermatitis: A Retrospective Case-Control Study
por: Rynhoud, Hester, et al.
Publicado: (2021)

Oclacitinib (APOQUEL®) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy
por: Gonzales, A J, et al.
Publicado: (2014)

Vaccine‐Associated Leptospira Antibodies in Client‐Owned Dogs
por: Martin, L.E.R., et al.
Publicado: (2014)

Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis
por: Nuttall, Tim, et al.
Publicado: (2014)

Identifying biomarkers of treatment response to ciclosporin in atopic dermatitis through multiomic predictive modelling: DERMATOMICS study protocol
por: Marín-Candón, Alicia, et al.
Publicado: (2023)

A blinded, randomized, placebo-controlled trial of the safety of oclacitinib in cats
por: Lopes, Natália Lôres, et al.
Publicado: (2019)

Acute Kidney Injury Due to Interaction of Methyl-1-testosterone with Ciclosporin Metabolism in a Patient with Severe Atopic Dermatitis
por: Al-Niaimi, Firas, et al.
Publicado: (2013)

Oclacitinib and Myxoma Virus Therapy in Dogs with High-Grade Soft Tissue Sarcoma
por: Ashton, Laura V., et al.
Publicado: (2023)

Evaluation of topical oclacitinib and nail trimming as a treatment for murine ulcerative dermatitis in laboratory mice
por: Davison, Steven E., et al.
Publicado: (2022)

Safety and toxicity of combined oclacitinib and carboplatin or doxorubicin in dogs with solid tumors: a pilot study
por: Barrett, Laura E., et al.
Publicado: (2019)

Impact of cytidine diphosphocholine on oxygenation in client‐owned dogs with aspiration pneumonia
por: Young, Anda A., et al.
Publicado: (2022)

Fatal disseminated toxoplasmosis in a feline immunodeficiency virus‐positive cat receiving oclacitinib for feline atopic skin syndrome
por: Moore, Alexandra, et al.
Publicado: (2022)

Atopic dermatitis and the intestinal microbiota in humans and dogs
por: Craig, J. Mark
Publicado: (2016)

Altered plasma cytokines in dogs with atopic dermatitis
por: Mazrier, Hamutal, et al.
Publicado: (2021)

Evaluation of renal values during treatment for heartworm disease in 27 client-owned dogs
por: Vetter, C. Autumn M., et al.
Publicado: (2023)

Vaccination against Extracellular Vimentin for Treatment of Urothelial Cancer of the Bladder in Client-Owned Dogs
por: Engbersen, Diederik J. M., et al.
Publicado: (2023)

Efficacy and safety of oral robenacoxib (tablet) for the treatment of pain associated with soft tissue surgery in client-owned dogs
por: Friton, Gabriele, et al.
Publicado: (2017)

Clinical Outcomes of Surgically Managed Spontaneous Tumors in 114 Client-owned Dogs
por: Choi, Ji-Won, et al.
Publicado: (2016)

Association between life span and body condition in neutered client‐owned dogs
por: Salt, Carina, et al.
Publicado: (2018)

Distribution of Cannabinoid Receptors in Keratinocytes of Healthy Dogs and Dogs With Atopic Dermatitis
por: Chiocchetti, Roberto, et al.
Publicado: (2022)

The effects of oclacitinib treatment on antimicrobial usage in allergic dogs in primary practice: an Australia wide case-control study
por: Rynhoud, Hester, et al.
Publicado: (2022)

Effects of cetirizine in dogs with chronic atopic dermatitis: a randomized, double blind, placebo-controlled trial
por: Hsiao, Yun-Hsia, et al.
Publicado: (2016)

Open field study on the efficacy of oral fluralaner for long-term control of flea allergy dermatitis in client-owned dogs in Ile-de-France region
por: Crosaz, Odile, et al.
Publicado: (2016)

Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib
por: Ashton, Laura V, et al.
Publicado: (2020)

Prevention of atopic dermatitis
por: Williams, Hywel C., et al.
Publicado: (2012)

Efficacy of Antimicrobial Treatment in Dogs with Atopic Dermatitis: An Observational Study
por: Sofou, Evi I., et al.
Publicado: (2022)

Clinical and histological recovery of non-thymoma-associated exfoliative dermatitis in a cat treated with ciclosporin A
por: Combarros, Daniel, et al.
Publicado: (2020)

Nasal Planum Vasculopathy in a Scottish Terrier Dog Treated with Ciclosporin and Endonasal Stents
por: Sartori, Roberta, et al.
Publicado: (2018)

Comparative study to evaluate the voluntary acceptance of two liquid oral formulations of ciclosporin in dogs
por: Kammanadiminti, Srinivas J., et al.
Publicado: (2018)

Clinical efficacy of spray‐based heat‐treated lactobacilli in canine atopic dermatitis: a preliminary, open‐label, uncontrolled study
por: Santoro, Domenico, et al.
Publicado: (2020)

Atopic dermatitis
por: Werfel, Thomas
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_gkij056idc86vblr5tbdb1umb1